Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

  • Bermejo Martin, Jesús F.
  • García Mateo, Nadia
  • Motos, Anna
  • Resino, Salvador
  • Tamayo, Luis
  • Ryan Murua, Pablo
  • Bustamante Munguira, Elena
  • Gallego Curto, Elena
  • Úbeda Iglesias, Alejandro
  • de la Torre, María del Carmen
  • Estella García, Ángel
  • Campos Fernández, Sandra
  • Martínez Varela, Ignacio
  • Pérez García, Felipe
  • Socias, Lorenzo
  • López Messa, Juan
  • Vidal Cortés, Pablo
  • Sagredo Meneses, Víctor
  • González Rivera, Milagros
  • Carbonell, Nieves
  • de Gonzalo Calvo, David
  • Martín Delgado, María Cruz
  • Valdivia, Luis Jorge
  • Martín López, Caridad
  • Jorge García, Ruth Noemí
  • Maseda, Emilio
  • Loza Vázquez, Ana
  • Kelvin, David J.
  • Barbé, Ferrán
  • Torres, Antoni
  • Ortega, Alicia
  • de la Fuente, Amanda
  • Almansa, Raquel
  • Postigo, Tamara
  • Jorge, Noelia
  • Tedim, Ana P.
  • González González, Laura
  • Sánchez Recio, Lara
  • Trapiello, Wysali
  • Berezo, José Ángel
  • Herrán Monge, Rubén
  • Blanco, Jesús
  • Enríquez, Pedro
  • Martínez, Isidoro
  • Martín Vicente, María
  • Muñoz Gómez, María José
  • Más, Vicente
  • Vázquez, Mónica
  • Cano, Olga
  • Martínez de la Gándara, Amalia
  • Rodríguez, Covadonga
  • Andrade, Gloria
  • Renedo, Gloria
  • Bustamante Munguira, Juan
  • Cicuendez Ávila, Ramón
  • Salgado Villén, María
  • Berruguilla Pérez, Enrique
  • Güell, Estel
  • Casadiego Monachello, Fernando Javier
  • Recuerda Núñez, María
  • Sánchez Calvo, Juan Manuel
  • Peñasco Martín, Yhivian
  • García Unzueta, María Teresa
  • Ceccato, Adrián
  • Fernández Barat, Laia
  • Bouza Vieiro, María Teresa
  • Moreno Romero, Ana
  • Pérez Bastida, Leire
  • del Río Carbajo, Lorena
  • Albalá Martínez, Noelia
  • Gómez, José Manuel
  • Blasco, María Luisa
  • Caballero, Jesús
  • Barberà, Carme
  • González, Jessica
  • Nieto, María Teresa
  • Nieto del Olmo, Jorge
  • Prol Silva, Estefanía
  • Canseco Ribas, Joan
  • Eiros, Jose María
Background: The contribution of the virus to the pathogenesis of severe COVID-19 is still unclear. We aimed to evaluate associations between viral RNA load in plasma and host response, complications, and deaths in critically ill patients with COVID-19. Methods: We did a prospective cohort study across 23 hospitals in Spain. We included patients aged 18 years or older with laboratory-confirmed SARS-CoV-2 infection who were admitted to an intensive care unit between March 16, 2020, and Feb 27, 2021. RNA of the SARS-CoV-2 nucleocapsid region 1 (N1) was quantified in plasma samples collected from patients in the first 48 h following admission, using digital PCR. Patients were grouped on the basis of N1 quantity: VIR-N1-Zero ([removed]2747 N1 copies per mL). The primary outcome was all-cause death within 90 days after admission. We evaluated odds ratios (ORs) for the primary outcome between groups using a logistic regression analysis. Findings: 1068 patients met the inclusion criteria, of whom 117 had insufficient plasma samples and 115 had key information missing. 836 patients were included in the analysis, of whom 403 (48%) were in the VIR-N1-Low group, 283 (34%) were in the VIR-N1-Storm group, and 150 (18%) were in the VIR-N1-Zero group. Overall, patients in the VIR-N1-Storm group had the most severe disease: 266 (94%) of 283 patients received invasive mechanical ventilation (IMV), 116 (41%) developed acute kidney injury, 180 (65%) had secondary infections, and 148 (52%) died within 90 days. Patients in the VIR-N1-Zero group had the least severe disease: 81 (54%) of 150 received IMV, 34 (23%) developed acute kidney injury, 47 (32%) had secondary infections, and 26 (17%) died within 90 days (OR for death 0·30, 95% CI 0·16–0·55; p<0·0001, compared with the VIR-N1-Storm group). 106 (26%) of 403 patients in the VIR-N1-Low group died within 90 days (OR for death 0·39, 95% CI 0·26–0·57; p[removed], 11 páginas
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Passive smoking at home is a risk factor for community-acquired pneumonia in older adults, a population-based case-control study

  • Almirall i Pujol, Jordi|||0000-0002-3821-4341
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Bolibar i Ribas, Ignasi|||0000-0002-4529-1935
  • Palomera, Elisabet|||0000-0002-4384-5746
  • Roig, Jordi
  • Hospital, Imma
  • Carandell, Eugenia
  • Agustí, Mercè
  • Ayuso, Pilar
  • Estela, Andreu
  • Torres, Antoni|||0000-0002-8643-2167
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia

  • Almirall i Pujol, Jordi|||0000-0002-3821-4341
  • Bolibar i Ribas, Ignasi|||0000-0002-4529-1935
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Palomera, Elisabet|||0000-0002-4384-5746
  • Roig, Jordi
  • Hospital, Imma
  • Carandell, Eugenia
  • Agustí, Mercè
  • Ayuso, Pilar
  • Estela, Andreu
  • Torres, Antoni|||0000-0002-8643-2167
The role of inhaled steroids in patients with chronic respiratory diseases is a matter of debate due to the potential effect on the development and prognosis of community-acquired pneumonia (CAP). We assessed whether treatment with inhaled steroids in patients with chronic bronchitis, COPD or asthma and CAP may affect early outcome of the acute pneumonic episode. Over 1-year period, all population-based cases of CAP in patients with chronic bronchitis, COPD or asthma were registered. Use of inhaled steroids were registered and patients were followed up to 30 days after diagnosis to assess severity of CAP and clinical course (hospital admission, ICU admission and mortality). Of 473 patients who fulfilled the selection criteria, inhaled steroids were regularly used by 109 (23%). In the overall sample, inhaled steroids were associated with a higher risk of hospitalization (OR=1.96, p = 0.002) in the bivariate analysis, but this effect disappeared after adjusting by other severity-related factors (adjusted OR=1.08, p=0.787). This effect on hospitalization also disappeared when considering only patients with asthma (OR=1.38, p=0.542), with COPD alone (OR=4.68, p=0.194), but a protective effect was observed in CB patients (OR=0.15, p=0.027). Inhaled steroids showed no association with ICU admission, days to clinical recovery and mortality in the overall sample and in any disease subgroup. Treatment with inhaled steroids is not a prognostic factor in COPD and asthmatic patients with CAP, but could prevent hospitalization for CAP in patients with clinical criteria of chronic bronchitis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inhaled amikacin for pneumonia treatment and dissemination prevention, an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia

  • Motos, Ana|||0000-0002-3757-1232
  • Yang, Hua
  • Li Bassi, Gianluigi
  • Yang, Minlan
  • Meli, Andrea
  • Battaglini, Denise
  • Cabrera, Roberto
  • Bobi, Joaquim|||0000-0002-9026-5226
  • Pagliara, Francesco
  • Frigola, Gerard|||0000-0001-6794-6456
  • Camprubí-Rimblas, Marta|||0000-0002-4085-5324
  • Fernández Barat, Laia|||0000-0001-7528-9636
  • Rigol, Montserrat
  • Ferrer-Segarra, Antoni
  • Kiarostami, Kasra
  • Martínez Hernández, Daniel|||0000-0001-7492-5311
  • Nicolau, David P.
  • Artigas Raventós, Antoni|||0000-0002-8029-1017
  • Pelosi, Paolo|||0000-0001-5055-3023
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Torres, Antoni|||0000-0002-8643-2167
Pseudomonas aerugino sa pneumonia is commonly treated with systemic antibiotics to ensure adequate treatment of multidrug resistant (MDR) bacteria. However, intravenous (IV) antibiotics often achieve suboptimal pulmonary concentrations. We therefore aimed to evaluate the effect of inhaled amikacin (AMK) plus IV meropenem (MEM) on bactericidal efficacy in a swine model of monolateral MDR P. aeruginosa pneumonia. We ventilated 18 pigs with monolateral MDR P. aeruginosa pneumonia for up to 102 h. At 24 h after the bacterial challenge, the animals were randomized to receive 72 h of treatment with either inhaled saline (control), IV MEM only, or IV-MEM plus inhaled AMK (MEM + AMK). We dosed IV MEM at 25 mg/kg every 8 h and inhaled AMK at 400 mg every 12 h. The primary outcomes were the P. aeruginosa burden and histopathological injury in lung tissue. Secondary outcomes included the P. aeruginosa burden in tracheal secretions and bronchoalveolar lavage fluid, the development of antibiotic resistance, the antibiotic distribution, and the levels of inflammatory markers. The median (25-75th percentile) P. aeruginosa lung burden for animals in the control, MEM only, and MEM + AMK groups was 2.91 (1.75-5.69), 0.72 (0.12-3.35), and 0.90 (0-4.55) log CFU/g (p = 0.009). Inhaled therapy had no effect on preventing dissemination compared to systemic monotherapy, but it did have significantly higher bactericidal efficacy in tracheal secretions only. Remarkably, the minimum inhibitory concentration of MEM increased to.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brewpitopes, a pipeline to refine B-cell epitope predictions during public health emergencies

  • Farriol-Duran, Roc
  • López-Aladid, Ruben
  • Porta-Pardo, Eduard|||0000-0001-7900-4239
  • Torres, Antoni|||0000-0002-8643-2167
  • Fernández Barat, Laia|||0000-0001-7528-9636
The application of B-cell epitope identification to develop therapeutic antibodies and vaccine candidates is well established. However, the validation of epitopes is time-consuming and resource-intensive. To alleviate this, in recent years, multiple computational predictors have been developed in the immunoinformatics community. Brewpitopes is a pipeline that curates bioinformatic B-cell epitope predictions obtained by integrating different state-of-the-art tools. We used additional computational predictors to account for subcellular location, glycosylation status, and surface accessibility of the predicted epitopes. The implementation of these sets of rational filters optimizes in vivo antibody recognition properties of the candidate epitopes. To validate Brewpitopes, we performed a proteome-wide analysis of SARS-CoV-2 with a particular focus on S protein and its variants of concern. In the S protein, we obtained a fivefold enrichment in terms of predicted neutralization versus the epitopes identified by individual tools. We analyzed epitope landscape changes caused by mutations in the S protein of new viral variants that were linked to observed immune escape evidence in specific strains. In addition, we identified a set of epitopes with neutralizing potential in four SARS-CoV-2 proteins (R1AB, R1A, AP3A, and ORF9C). These epitopes and antigenic proteins are conserved targets for viral neutralization studies. In summary, Brewpitopes is a powerful pipeline that refines B-cell epitope bioinformatic predictions during public health emergencies in a high-throughput capacity to facilitate the optimization of experimental validation of therapeutic antibodies and candidate vaccines.